These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9788760

  • 1. Surface retention of an inactivating lutropin receptor mutant in exoloop 3.
    Bhowmick N, Narayan P, Puett D.
    Mol Cell Biochem; 1998 Oct; 187(1-2):221-7. PubMed ID: 9788760
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA, Narayan P, Huang J, Puett D.
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [Abstract] [Full Text] [Related]

  • 3. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K, Narayan P, Simon JP, Puett D.
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [Abstract] [Full Text] [Related]

  • 4. Evidence for an important functional role of intracellular loop II of the lutropin receptor.
    Fernandez LM, Puett D.
    Mol Cell Endocrinol; 1997 Apr 04; 128(1-2):161-9. PubMed ID: 9140087
    [Abstract] [Full Text] [Related]

  • 5. Effects of truncations of the cytoplasmic tail of the luteinizing hormone/chorionic gonadotropin receptor on receptor-mediated hormone internalization.
    Rodriguez MC, Xie YB, Wang H, Collison K, Segaloff DL.
    Mol Endocrinol; 1992 Mar 04; 6(3):327-36. PubMed ID: 1316539
    [Abstract] [Full Text] [Related]

  • 6. Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive.
    Narayan P, Gray J, Puett D.
    Mol Endocrinol; 2002 Dec 04; 16(12):2733-45. PubMed ID: 12456794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor.
    Nakamura K, Lazari MF, Li S, Korgaonkar C, Ascoli M.
    Mol Endocrinol; 1999 Aug 04; 13(8):1295-304. PubMed ID: 10446904
    [Abstract] [Full Text] [Related]

  • 10. Exoloop 3 of the luteinizing hormone/choriogonadotropin receptor. Lys583 is essential and irreplaceable for human choriogonadotropin (hCG)-dependent receptor activation but not for high affinity hCG binding.
    Ryu KS, Gilchrist RL, Ji I, Kim SJ, Ji TH.
    J Biol Chem; 1996 Mar 29; 271(13):7301-4. PubMed ID: 8631747
    [Abstract] [Full Text] [Related]

  • 11. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the Lutropin/Choriogonadotropin receptor.
    Min KS, Liu X, Fabritz J, Jaquette J, Abell AN, Ascoli M.
    J Biol Chem; 1998 Dec 25; 273(52):34911-9. PubMed ID: 9857020
    [Abstract] [Full Text] [Related]

  • 12. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
    Schubert RL, Narayan P, Puett D.
    Endocrinology; 2003 Jan 25; 144(1):129-37. PubMed ID: 12488338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lutropins appear to contact two independent sites in the extracellular domain of their receptors.
    Bernard MP, Myers RV, Moyle WR.
    Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):611-7. PubMed ID: 9794802
    [Abstract] [Full Text] [Related]

  • 15. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H, Fanelli F, Liu X, Jaquette J, Nakamura K, Segaloff DL.
    Mol Endocrinol; 2001 Jun 01; 15(6):972-84. PubMed ID: 11376115
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation.
    Wang Z, Hipkin RW, Ascoli M.
    Mol Endocrinol; 1996 Jun 01; 10(6):748-59. PubMed ID: 8776735
    [Abstract] [Full Text] [Related]

  • 18. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K, Kohn LD, Saji M, Okuno A, Cutler GB.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2586-91. PubMed ID: 9253338
    [Abstract] [Full Text] [Related]

  • 19. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells.
    Gudermann T, Birnbaumer M, Birnbaumer L.
    J Biol Chem; 1992 Mar 05; 267(7):4479-88. PubMed ID: 1311310
    [Abstract] [Full Text] [Related]

  • 20. Leutropin/beta-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface.
    Moyle WR, Bernard MP, Myers RV, Marko OM, Strader CD.
    J Biol Chem; 1991 Jun 15; 266(17):10807-12. PubMed ID: 1645710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.